Startups

You are here

Startup Companies Formed at the University of Illinois at Chicago

There are currently more than 30 active launched startups based on the University of Illinois at Chicago IP. 

Our portfolio of companies includes: 

 

Actuate Therapeutics

Developing novel therapeutics that have implications in many conditions, including cancer, Alzheimer’s disease, bipolar disorder, diabetes mellitus type II, and inflammatory conditions leading to fibrosis.

Cell Biologics

Manufacturing primary cultured cells and cell culture products to provide a broad range of high-quality human and animal primary cells including endothelial, epithelial, tumor and stem cells, along with optimized cell culture media and other related products.

Crop Growers LLC

Utilizes satellite-derived imagery combined with ground-based observations to provide crop condition and production information for grain buyers and commodity analysts.

EnteroTrack

EnteroTrack LLC is developing a capsule that can help identify the presence of esophageal inflammation, leading to faster treatment.

ImmersiveTouch

ImmersiveTouch® is a leader in simulation based surgical training and exploration. ImmersiveTouch simulators ‘immerse’ surgeons in a digitally replicated operating environment with high-fidelity 3D virtual anatomies and haptic instrument replicates.

NetEnergy

NETenergy has created a thermal battery, that works much like an electrical battery, except it stores thermal energy.

OpinionEQ

Collecting, interpreting, and structuring web and real-time communications to determine what people are saying about a company and its products and how they are saying it. 

Progenicyte Therapeutics

Harnessing of the power of human neural stem cells. 

Simplified Data Tracking, Inc.

Offering data management solutions that allow scientists to store, track, and analyze information for transgenic and knockout mouse colonies, cell and bacterial storage freezers, plasmid constructs and PCR primers. 

Triangle Therapeutics

Triangle Therapeutics develops deoxycytidine kinase (dCK) inhibitors for treatment of Acute Lymphoblastic Leukemia (ALL) and as well as other oncological diseases.

Aurora MicroArray Solutions

Aurora Microarray Solutions works with researchers and industry to design custom microarray diagnostics and instrumentation from initial concept through data analysis and reporting.

Cell Habitats

Redefining the field of tissue regeneration by harnessing the body's own endogenous stem cells to restore normal function to damaged or diseased tissue. 

DuPage Medical Technologies

Developing a small peptide based inhibitor into a new type of anti-thrombotic drugs that are more effective in narrowed arteries and less bleeding adverse effect.

Immune Cell Therapy

A therapeutics company developing a cell-based vaccine treatment for cancer patients with a focus on lung and breast cancer.

Jivana Biotechnology

Pursuing therapies for breast, ovarian, thyroid, neuroblastoma, and glioblastoma cancers through the use of RNAi (RNA interference or Gene Silencing) techniques. 

NexHand

A medical device company developing highly innovative technology to improve the diagnosis and surgical procedures of patients suffering from stress urinary incontinence (SUI).  

PAX

Developing protein biomarker-based clinical laboratory services and products that address unmet needs in the fields of Neuroscience and Psychiatry.

Rochester Medical Technologies

Commercializes clinical-grade diagnostic and monitoring medical technologies with an emphasis on technologies that can "recognize and respond" to immediate threats to life-and-limb associated with acute medical emergencies.

Tianhe

A stem cell biotechnolgoy company the is developing treatment for type 1 diabetes. 

TTC Oncology

Advancing drug therapy for the treatment of Tamoxifen-resistant breast cancer.

YASO Therapeutics, Inc.

Developing drugs for multi-purpose treatment products for herpes simplex as well as prophylactic for genital herpes and conception.

Vista Oncology

Developing therapeutics to address the unmet needs of breast cancer patients.